Himalaya Nutravedics India IPO
LiveQuality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Himalaya Nutravedics India IPO Details
-
Bidding Date
22-Sep-2026 to
24-Sep-2026 -
Issue Size
₹26.5 Cr
-
Price Band
₹100 to ₹106
-
Allotment date
25-Sep-2026
-
Listing date
To be updated
-
Lot size
1200
-
No. of shares
24,99,600
-
Fresh issue/OFS
₹26.5 Cr /--
About Himalaya Nutravedics India Company
Himalaya Nutravedics India, incorporated in June 2022 and commencing manufacturing operations later that year, is a Hyderabad-based Ayurvedic and nutraceutical company that has developed a hybrid model combining its own branded products with third-party contract manufacturing for other healthcare businesses. Its core activities cover formulation, manufacturing, marketing and distribution, with a portfolio spanning classical Ayurvedic formulations based on recognised texts, proprietary Ayurvedic products and nutraceutical supplements containing ingredients such as herbal extracts, vitamins, minerals and amino acids. Products are offered as softgel and hardgel capsules, tablets, liquid orals, medicated oils and protein powders, addressing digestive, immune, metabolic, cardiac, musculoskeletal, pain-management, reproductive, maternal, paediatric and general-wellness needs. The company’s expertise lies in multi-dosage-form production, Ayurvedic formulation development, quality-controlled manufacturing and client-specific contract services covering formulation, production, packaging and dispatch; its integrated Hyderabad facility holds WHO-GMP, ISO 9001:2015 and ISO 22000:2018 certifications. Its customers include healthcare practitioners, pharmacies, stockists, distributors, institutional buyers and other Ayurvedic and nutraceutical brands, while its branded products are promoted through a doctor-centric field-sales and offline distribution network across 17 states and one union territory. Himalaya Nutravedics engages clients through specification-led manufacturing, practitioner-oriented product communication and supply-chain support, seeking to combine traditional Ayurvedic knowledge with contemporary dosage forms and nutraceutical development while addressing demand for accessible, standardized and wellness-focused healthcare products.
Subscription Status
-
Category
Status
-
QIBs
--
-
NIIs
--
-
Retail
0.1x
-
Others
--
-
Total
0.1x
FAQs for Himalaya Nutravedics India IPO.
What is the issue size of Himalaya Nutravedics India IPO?
The issue size of Himalaya Nutravedics India is ₹26.50 Cr.
What is the industry of Himalaya Nutravedics India?
Himalaya Nutravedics India falls into Pharmaceuticals industry.
What are the open and close dates for the Himalaya Nutravedics India IPO?
The open and close dates for the Himalaya Nutravedics India are 22-Sep-2026 & 24-Sep-2026.
What are the price band for Himalaya Nutravedics India IPO?
The price band for the Himalaya Nutravedics India ipo is ₹100 to ₹106
What is the purpose for the Himalaya Nutravedics India IPO?
The purpose of this IPO is to raise fresh capital.
How much times Himalaya Nutravedics India IPO subscribed?
Himalaya Nutravedics India total subscription ratio is 0.1X.
What are the key financials for the Himalaya Nutravedics India IPO?
Key financial of the Himalaya Nutravedics India are:
| Himalaya Nutravedics India | FY-26 | FY-25 | FY-24 |
|---|---|---|---|
| Revenue (₹ Cr) | 43.07 | 21 | 14.43 |
| EBIT (₹ Cr) | 7.78 | 2.57 | 0.78 |
| Proft after Tax (₹ Cr) | 7.39 | 2.23 | 0.43 |
| Debt (₹ Cr) | 5.13 | 1.76 | 3.24 |
| Net Worth (₹ Cr) | 16.38 | 6.76 | 1.36 |
| RoE (%) | 45.11 | 33.03 | 31.43 |